Dianthus Therapeutics (DNTH) Other Gross PP&E Adjustments: 2017-2025
Historic Other Gross PP&E Adjustments for Dianthus Therapeutics (DNTH) over the last 4 years, with Sep 2025 value amounting to -$844,000.
- Dianthus Therapeutics' Other Gross PP&E Adjustments fell 21200.00% to -$844,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.1 million, marking a year-over-year decrease of 84.29%. This contributed to the annual value of -$10.3 million for FY2024, which is 51.83% down from last year.
- Dianthus Therapeutics' Other Gross PP&E Adjustments amounted to -$844,000 in Q3 2025, which was up 8.36% from -$921,000 recorded in Q2 2025.
- Dianthus Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $4,000 for Q3 2024, and its period low was -$25.4 million during Q1 2022.
- In the last 3 years, Dianthus Therapeutics' Other Gross PP&E Adjustments had a median value of -$921,000 in 2025 and averaged -$2.1 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first spiked by 100.94% in 2024, then plummeted by 21,200.00% in 2025.
- Dianthus Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$915,000 in 2022, then tumbled by 642.62% to -$6.8 million in 2023, then plummeted by 51.83% to -$10.3 million in 2024, then tumbled by 21,200.00% to -$844,000 in 2025.
- Its last three reported values are -$844,000 in Q3 2025, -$921,000 for Q2 2025, and -$1.0 million during Q1 2025.